Y.-J. An et al. / Tetrahedron: Asymmetry 21 (2010) 688–694
693
2.8 Hz, CH), 6.85 (d, J = 8.0 Hz, 1H, Ar-H), 6.97 (t, J = 8.0 Hz, 1H, Ar-
H), 7.24 (t, J = 8.0 Hz, 1H, Ar-H), 7.43 (d, J = 8.0 Hz, 1H, Ar-H);
1H), 7.49 (d, J = 8.4 Hz, 2H), 8.22 (d, J = 8.4 Hz, 2H); anti: 1.36–
1.44 (m, 1H), 1.51–1.73 (m, 3H), 1.83 (m, 1H), 2.10–2.15 (m, 1H),
2.33–2.46 (m, 1H), 2.50 (m, 1H), 2.57–2.63 (m, 1H), 3.80 (br, 1H),
4.90 (d, J = 8.4 Hz, 1H), 7.51 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 8.4 Hz,
2H); HPLC (for anti): Chiralcel OD-H, UV 254 nm, i-PrOH/hex-
ane = 5/95, flow rate 1.0 mL/min, tR 32.3 min (major), tR 50.8 min
(minor).
½
a 2D0
ꢀ
¼ þ76:8 (c 0.54); Enantiomeric excess: 81%, determined by
HPLC: Chiralpak AD-H, UV 220 nm, i-PrOH/hexane = 10/90, flow
rate 1.0 mL/min, (R)-isomer, tR 11.1 min, (S)-isomer, tR 12.6 min.
4.3.1.8. 4-Hydroxyl-4-(4-bromophenyl)butan-2-one. 1H NMR
(CDCl3) d: 2.18 (s, 3H, CH3), 2.73–2.86 (m, 2H, CH2), 3.36 (br, 1H,
OH), 5.08 (dd, J = 8.8, 3.6 Hz, 1H, CH), 7.21 (d, J = 8.4 Hz, 2H, Ar-
4.3.2.4. 2-[Hydroxy-(2-chlorophenyl)methyl]cyclohexanone.
1H NMR (CDCl3) d: syn: 1.53–1.71 (m, 4H), 1.81–1.84 (m, 1H),
2.08 (m, 1H), 2.33–2.42 (m, 1H), 2.48 (m, 1H), 2.81 (m, 1H), 3.95
(s, 1H), 5.72 (d, J = 2.0 Hz, 1H), 7.20–7.34 (m, 3H), 7.56 (d,
J = 8.0 Hz, 1H); anti: 1.53–1.84 (m, 5H), 2.05–2.13 (m, 1H), 2.31–
2.39 (m, 1H), 2.46–2.49 (m, 1H), 2.65–2.71 (m, 1H), 3.88 (s, 1H),
5.35 (d, J = 8.0 Hz, 1H), 7.20–7.34 (m, 3H), 7.56 (d, J = 8.4 Hz, 1H);
HPLC (for anti): Chiralcel OD-H, UV 220 nm, i-PrOH/hexane = 5/
95, flow rate 1.0 mL/min, tR 10.0 min (major), tR 13.7 min (minor).
H), 7.45 (d, J = 8.4 Hz, 2H, Ar-H); ½a D20
¼ þ50:7 (c 0.70); Enantio-
ꢀ
meric excess: 82%, determined by HPLC: Chiralpak AD-H, UV
220 nm, i-PrOH/hexane = 10/90, flow rate 0.8 mL/min, (R)-isomer,
tR 12.7 min, (S)-isomer, tR 14.0 min.
4.3.1.9. 4-Hydroxyl-4-pyridylbutan-2-one. 1H NMR (CDCl3) d:
2.21 (s, 2H, CH3), 2.87–2.94 (dd, J = 17.2, 8.8 Hz, 1H), 3.02–3.07
(dd, J = 17.2, 3.6 Hz, 1H), 4.35 (bra, 1H), 5.18–5.21 (dd, J = 8.4,
3.6 Hz, 1H), 7.18–7.21 (dd, J = 6.8, 5.6 Hz, 1H), 7.45–7.47 (d,
J = 8.0 Hz, 1H), 7.68–7.72 (m, 1H), 8.51–8.52 (d, J = 4.4 Hz, 1H).
4.3.2.5. 2-[Hydroxy-(4-chlorophenyl)methyl]cyclohexanone.
1H NMR (CDCl3) d: syn: 1.42–2.11 (m, 6H), 2.32–2.45 (m, 2H),
2.53–2.56 (m, 1H), 3.05 (s, 1H), 5.36 (d, J = 2.0 Hz, 1H), 7.24 (d,
J = 8.4 Hz, 2H), 7.32 (d, J = 8.4 Hz, 2H); anti: 1.27–1.31 (m, 1H),
1.53–1.82 (m, 4H), 2.07–2.11 (m, 1H), 2.35–2.56 (m, 3H), 4.76
(d, J = 8.8 Hz, 1H), 7.26 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 8.0 Hz,
2H); HPLC (for anti): Chiralcel OD-H, UV 220 nm, i-PrOH/hex-
ane = 5/95, flow rate 1.0 mL/min, tR 13.6 min (major), tR
23.3 min (minor).
½
a 2D0
ꢀ
¼ þ44:0 (c 0.40); Enantiomeric excess: 75%, determined by
HPLC: Chiralpak AD-H, UV 254 nm, i-PrOH/hexane = 10/90, flow
rate 0.5 mL/min, (R)-isomer, tR 24.5 min, (S)-isomer, tR 28.0 min.
4.3.1.10. 4-Hydroxyl-4-phenylbutan-2-one. 1H NMR (CDCl3) d:
2.13 (s, 3H, CH3), 2.74 (dd, J = 17.2, 3.2 Hz, 1H), 2.85 (dd, J = 17.2,
9.6 Hz, 1H), 3.63 (br, 1H, OH), 5.10 (dd, J = 9.6, 3.2 Hz, 1H, CH),
7.24–7.32 (m, 5H, Ar-H); ½a D20
¼ þ63:1 (c 0.66); Enantiomeric
ꢀ
excess: 79%, determined by HPLC: Chiralpak AD-H, UV 254 nm,
i-PrOH/hexane = 10/90, flow rate 0.6 mL/min, (R)-isomer, tR
25.2 min, (S)-isomer, tR 28.6 min.
4.3.2.6. 2-[Hydroxy-(4-bromophenyl)methyl]cyclohexanone.
1H NMR (400 MHz, CDCl3) d: syn: 1.55–1.86 (series of m, 5H,
CH2), 2.08 (m, 1H, CH2), 2.44–2.46 (m, 3H, CH), 3.06 (br s, 1H,
OH), 5.33 (s, 1H, CH), 7.19 (d, J = 8.4 Hz, 2H, ArH), 7.48 (d,
J = 8.4 Hz, 2H, ArH); anti: 1.20–1.35 (m, 1H, CH2), 1.40–1.85 (m,
4H, CH2), 2.07 (m, 1H, CH2), 2.36–2.37 (m, 2H, CH2), 2.53–2.55
(m, 1H, CH), 3.98 (br s, 1H, OH), 4.73–4.76 (d, J = 8.8 Hz, 1H,
CH), 7.17 (d, J = 8.4 Hz, 2H, ArH), 7.47 (d, J = 8.4 Hz, 2H, ArH);
HPLC (for anti): Chiralcel AD-H, UV 220 nm, i-PrOH/hex-
ane = 10/90, flow rate 0.8 mL/min, tR 20.4 min (major), tR
23.2 min (minor).
4.3.2. General procedure for condensations of cyclohexanone
and aromatic aldehydes
Aldehyde (0.33 mmol) was added to the mixture of 5 equiv
cyclohexanone, 5 equiv water, and 1 mol % of catalyst under
25 °C. Then the reaction mixture was stirred for the indicated time,
purified by thin layer chromatography on silica gel (petroleum
ether/ethyl acetate).
4.3.2.1. 2-[Hydroxy-(2-nitrophenyl)methyl]cyclohexanone. 1H
NMR (CDCl3) d: syn: 1.53–1.87 (m, 6H, 3CH2), 2.10 (m, 1H), 2.42–
2.47 (m, 2H), 2.87–2.91 (dd, J = 13.2, 4.8 Hz, 1H, CH), 3.15 (br, 1H,
OH), 5.96 (d, J = 1.6 Hz, 1H, CHOH), 7.46 (td, J = 8.0, 0.8 Hz, 1H,
Ar-H), 7.66 (td, J = 8.0, 0.8 Hz, 1H, Ar-H), 7.84 (dd, J = 8.0, 0.8 Hz,
1H, Ar), 8.02 (dd, J = 8.0, 0.8 Hz, 1H, Ar-H); anti: 1.61–1.87 (m,
6H), 2.10 (m, 1H), 2.34–2.47 (m, 2H), 2.77 (m, 1H), 3.95 (br, 1H),
5.45 (d, J = 7.2 Hz, 1H), 7.44 (d, J = 8.0, 0.8 Hz, 1H, Ar-H), 7.66 (d,
J = 8.0, 0.8 Hz, 1H, Ar-H), 7.78 (dd, J = 8.0, 0.8 Hz, 1H), 7.86 (dd,
J = 8.0, 0.8 Hz, 1H); HPLC (for anti): Chiralcel OD-H, UV 254 nm, i-
PrOH/hexane = 5/95, flow rate 0.5 mL/min, tR 36.6 min (major), tR
45.5 min (minor).
4.3.2.7. 2-[Hydroxy-(4-flurophenyl)methyl]cyclohexanone. 1H
NMR (CDCl3) d: syn: 1.50–1.87 (m, 5H), 1.84–1.88 (m, 1H), 2.36–
2.56 (m, 3H), 3.05 (br, 1H), 5.36 (d, J = 1.6 Hz, 1H), 7.00–7.05 (m,
2H), 7.25–7.29 (m, 2H); anti: 1.24–1.33 (m, 1H), 1.53–1.82 (m,
4H), 2.07–2.12 (m, 1H), 2.35–2.59 (m, 3H), 4.01 (s, 1H), 4.77 (d,
J = 8.8 Hz, 1H), 7.01–7.05 (m, 2H), 7.27–7.31 (m, 2H); HPLC (for
anti): Chiralcel OD-H, UV 254 nm, i-PrOH/hexane = 5/95, flow rate
1.0 mL/min, tR 12.7 min (major), tR 28.5 min (minor).
4.3.2.8. 2-[Hydroxy-phenylmethyl]cyclohexanone. 1H NMR
(400 MHz, CDCl3): d: syn: 1H NMR (400 MHz, CDCl3): d: 1.61–
1.78 (m, 4H, CH2), 2.08–2.09 (m, 1H, CH2), 2.38–2.48 (m, 2H, CH),
2.62 (m, 1H, CH), 5.41 (s, 1H, CH), 7.31–7.36 (m, 5H, ArH); anti:
1.30–1.33 (m, 1H, CH2), 1.57–1.78 (m, 4H, CH2), 2.08–2.09 (m,
1H, CH2), 2.37–2.48 (m, 2H, CH), 2.62–2.64 (m, 1H, CH), 4.79–
4.82 (d, J = 8.8 Hz, 1H, CH), 7.28–7.36 (m, 5H, ArH); HPLC (for anti):
Chiralcel OD-H, UV 254 nm, i-PrOH/hexane = 5/95, flow rate
1.0 mL/min, tR 13.4 min (major), tR 24.0 min (minor).
4.3.2.2. 2-[Hydroxy-(3-nitrophenyl)methyl]cyclohexanone. 1H
NMR (CDCl3) d: syn: 1.48–2.10 (m, 6H), 2.33–2.48 (m, 2H), 2.62–
2.66 (m, 1H), 3.16 (s, 1H), 5.48 (d, J = 2.0 Hz, 1H), 7.52 (t,
J = 8.0 Hz, 1H), 7.66 (d, J = 1.4 Hz, 1H), 8.11 (d, J = 8.0 Hz, 1H),
8.20 (d, J = 8.0 Hz, 1H); anti: 1.33–2.10 (m, 6H), 2.32–2.48 (m,
2H), 2.70 (m, 1H), 3.16 (s, 1H), 4.91 (d, J = 8.4 Hz, 1H), 7.54 (t,
J = 8.0 Hz, 1H), 7.68 (d, J = 0.8 Hz, 1H), 8.15 (m, J = 8.0 Hz, 1H),
8.20 (d, J = 8.0 Hz, 1H); HPLC (for anti): Chiralcel OD-H, UV
254 nm, i-PrOH/hexane = 5/95, flow rate 1.0 mL/min, tR 26.5 min
(major), tR 41.9 min (minor).
4.3.2.9. 2-[Hydroxy-(2-methoxyphenyl)methyl]cyclohexanone.
1H NMR (CDCl3) d: syn: 1.49–1.87 (m, 5H), 1.84–1.89 (m, 1H),
2.36–2.56 (m, 3H), 3.05 (br, 1H), 5.39 (d, J = 1.6 Hz, 1H), 6.85 (d,
J = 8.0 Hz, 1H, Ar-H), 6.97 (t, J = 8.0 Hz, 1H, Ar-H), 7.24 (t,
J = 8.0 Hz, 1H, Ar-H), 7.43 (d, J = 8.0 Hz, 1H, Ar-H) anti: 1.30–1.98
(m, 6H), 2.30–2.46 (m, 3H), 3.00 (br, 1H), 4.78 (d, J = 1.6 Hz, 1H),
6.88 (d, J = 8.0 Hz, 1H, Ar-H), 6.97 (t, J = 8.0 Hz, 1H, Ar-H), 7.25 (t,
4.3.2.3. 2-[Hydroxy-(4-nitrophenyl)methyl]cyclohexanone. 1H
NMR (CDCl3) d: syn: 1.50–1.88 (m, 5H), 2.09–2.15 (m, 1H), 2.37–
2.52 (m, 2H), 2.62–2.66 (m, 1H), 3.10 (br, 1H), 5.49 (d, J = 1.6 Hz,